Evolent Health’s (EVH) Market Outperform Rating Reiterated at JMP Securities

Evolent Health (NYSE:EVH)‘s stock had its “market outperform” rating reiterated by JMP Securities in a report released on Friday,Benzinga reports. They presently have a $12.00 price objective on the technology company’s stock. JMP Securities’ target price points to a potential upside of 19.23% from the company’s current price.

Other research analysts have also issued reports about the company. Truist Financial cut their target price on Evolent Health from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, January 22nd. Royal Bank of Canada dropped their price objective on shares of Evolent Health from $20.00 to $17.00 and set an “outperform” rating for the company in a research note on Tuesday, January 14th. BTIG Research lowered their target price on shares of Evolent Health from $36.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Canaccord Genuity Group cut their price target on shares of Evolent Health from $23.00 to $16.00 and set a “buy” rating for the company in a research note on Thursday, January 23rd. Finally, Stephens lowered their price objective on Evolent Health from $16.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 21st. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $17.92.

Evolent Health Trading Up 1.0 %

Shares of EVH opened at $10.07 on Friday. The stock’s 50-day moving average price is $10.86 and its 200 day moving average price is $19.24. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of -11.06 and a beta of 1.45. Evolent Health has a 12-month low of $9.45 and a 12-month high of $35.00.

Hedge Funds Weigh In On Evolent Health

Institutional investors have recently bought and sold shares of the business. Wellington Management Group LLP grew its holdings in shares of Evolent Health by 12.8% during the third quarter. Wellington Management Group LLP now owns 12,595,459 shares of the technology company’s stock worth $356,200,000 after purchasing an additional 1,426,747 shares during the last quarter. Vanguard Group Inc. grew its holdings in Evolent Health by 2.4% during the 4th quarter. Vanguard Group Inc. now owns 11,171,199 shares of the technology company’s stock worth $125,676,000 after acquiring an additional 259,781 shares during the last quarter. Engaged Capital LLC grew its holdings in Evolent Health by 35.5% during the 4th quarter. Engaged Capital LLC now owns 5,404,768 shares of the technology company’s stock worth $60,804,000 after acquiring an additional 1,415,300 shares during the last quarter. Eventide Asset Management LLC increased its position in Evolent Health by 1.7% in the 3rd quarter. Eventide Asset Management LLC now owns 3,804,104 shares of the technology company’s stock valued at $107,580,000 after acquiring an additional 64,985 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Evolent Health by 19.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,897,443 shares of the technology company’s stock worth $32,595,000 after acquiring an additional 466,225 shares during the last quarter.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.